César Daniel Alonso-Bello

5PUBLICATIONS
30CO-AUTHORS
AllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 31, 2026
[Hypersensitivity to iodinated contrast media: Diagnostic and therapeutic strategies. Position Statement of the Drug Allergy Committee of the Mexican College of Clinical Immunology and Allergy].

Rosalaura Virginia Villarreal González, Nataly Anais Flores García, Leslie Astrid de la Fuente

|Apr 20, 2025
[Adverse reactions due to monoclonal antibodies in the treatment of allergic diseases. Group Positioning: Comité de Alergia a Medicamentos del Colegio Mexicano de Inmunología Clínica y Alergia (CMICA 2024-2025)].

Rosalaura Virginia Villarreal-González, Pablo Perea-Valle, Alira Fraga-Olvera

|Feb 25, 2021
Erratum to "Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome".

Cesar Daniel Alonso-Bello, María Del Carmen Jiménez-Martínez, María Eugenia Vargas-Camaño

|Jun 09, 2020
The Effects of Alternate-Day Corticosteroids in Autoimmune Disease Patients.

Genny Margarita Chaia-Semerena, María Eugenia Vargas-Camaño, Cesar Daniel Alonso-Bello

|Jul 30, 2019
Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome.

Cesar Daniel Alonso-Bello, María Del Carmen Jiménez-Martínez, María Eugenia Vargas-Camaño

Pageof 1